FDA approves new drug to protect against RSV in infants
Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.
Jul 18, 2023
0
7